Biocryst Pharmaceuticals Inc SC 13D and SC 13D/A reports

Location
4505 Emperor Boulevard, Suite 200, Durham, North Carolina
State of incorporation
Delaware
Fiscal year end
December 31
Data updated at
6/14/2024, 01:21 AM
Form type Sec Links Description Filing date Reporting date
SC 13D/A Report Jul 31, 2018
SC 13D/A Report Jun 20, 2018
SC 13D Report Apr 2, 2018
SC 13D Report Feb 16, 2018
SC 13D/A Report SC 13D/A Aug 16, 2016
SC 13D/A Report AMENDMENT TO SC 13D Feb 4, 2016
SC 13D Report SCHEDULE 13D Nov 6, 2015
SC 13D/A Report SCHEDULE 13D/A Aug 2, 2013
SC 13D/A Report SC 13D/A Jul 11, 2013
SC 13D/A Report SC 13D/A Oct 23, 2012
SC 13D/A Report SC 13D/A Apr 23, 2012
SC 13D/A Report SC 13D/A Oct 13, 2011